Gestalt and Primaa Partner to Enhance Skin Cancer Detection with AI

Mar 20, 2025
Gestalt and Primaa have announced a strategic partnership to integrate AI technology for skin cancer diagnosis into Gestalt's PathFlow platform, enhancing diagnostic precision and workflow efficiency.

Gestalt Diagnostics and Primaa have announced a strategic partnership to integrate AI technology for skin cancer diagnosis into Gestalt's PathFlow platform, announced in a press release. This collaboration aims to enhance diagnostic precision and workflow efficiency for pathologists.

Primaa's advanced AI algorithms will be integrated into the PathFlow platform, allowing pathologists to detect and quantify tumor biomarkers in skin tissues more effectively. The AI-driven tools can automatically identify lesion types such as melanoma, squamous cell carcinoma, and basal cell carcinoma, providing detailed measurements of lesion dimensions and margins.

The system also prioritizes high-risk cases for immediate review, ensuring timely and accurate diagnosis. This partnership underscores both companies' commitment to leveraging AI technology to improve patient outcomes in skin cancer diagnostics.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.